Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2019 17:15 ET | Source: Synthorx, Inc.

Synthorx to Present at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

SAN DIEGO, May 15, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company discovering and developing optimized biologics for cancer and autoimmune disorders, today announced...
April 30, 2019 16:05 ET | Source: Synthorx, Inc.

Synthorx Reports First Quarter Financial Results

SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
April 02, 2019 08:00 ET | Source: Synthorx, Inc.

Synthorx to Present at H.C. Wainwright Global Life Sciences Conference in London

SAN DIEGO, April 02, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
March 19, 2019 08:00 ET | Source: Synthorx, Inc.

Synthorx to Present at the American Association of Cancer Research (AACR) Annual Meeting 2019

SAN DIEGO, March 19, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
March 12, 2019 16:05 ET | Source: Synthorx, Inc.

Synthorx Reports Fourth Quarter and Full Year 2018 Financial Results

Company Positioned for Upcoming 2019 Milestones After Successful IPO Raising $150.7 Million in Gross Proceeds Presented Preclinical Safety and Anti-Tumor Data on Lead Product Candidate THOR-707 at...
March 12, 2019 08:00 ET | Source: Synthorx, Inc.

Synthorx to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy

SAN DIEGO, March 12, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
February 21, 2019 16:05 ET | Source: Synthorx, Inc.

Synthorx to Present at the 8th Annual SVB Leerink Global Healthcare Conference

SAN DIEGO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
December 20, 2018 08:00 ET | Source: Synthorx, Inc.

Synthorx Appoints Andrew Powell, J.D., to its Board of Directors

SAN DIEGO, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
December 12, 2018 16:05 ET | Source: Synthorx, Inc.

Synthorx Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
December 06, 2018 21:15 ET | Source: Synthorx, Inc.

Synthorx Announces Pricing of Initial Public Offering

SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...